H&Q Life Sciences Investors renews share buyback authority of up to 12% of shares
H&Q Life Sciences Investors said its Board of Trustees authorized a renewal of the Fund's share repurchase program. The renewed program would let the Fund buy up to 12% of its outstanding common shares in the open market for one year, starting July 11, 2012, after the current program ends on July 10, 2012. The Board said the aim is to increase net asset value per share and possibly narrow the discount between market price and net asset value.
Key points
- Renewed program allows open-market purchases of up to 12% of outstanding common shares
- Current program runs through July 10, 2012; renewal covers the one-year period beginning July 11, 2012
- Repurchase amount and timing are at the discretion of Hambrecht & Quist Capital Management LLC, the Fund's adviser
- The filing states there is no assurance shares will be bought at any specific discount or amount, or that market price will rise
The filing
Written by AI on Nov 9, 2026, 8:29 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on March 23, 2012.
Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.